|
|
||||||||
Articles |
Department of Pediatrics, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
a Author for correspondence. Fax 43 1 40400 3238; e-mail franz.waldhauser{at}akh-wien.ac.at.
We optimized an RIA for measurement of arginine8-vasopressin (AVP) in plasma by use of 100-mg Isolute C18 columns for extraction, addition of a preincubation step, and use of maximal dilution of a commercially available antiserum. The detection limit was 0.06 ng/L when 0.5 mL of acidified plasma was extracted. The within- and between-run CVs (n = 16) at physiological concentrations were 5.810.2% and 6.511.7%, respectively. Prolonged storage of blood at 25 °C, but not at 4 °C, led to a significant increase in measured plasma AVP concentrations. When plasma samples were prepared at several centrifugation speeds, plasma AVP was significantly correlated with the platelet count (r = 0.899; P <0.001). This emphasizes the need for careful sample preparation to avoid contamination of plasma with platelet-bound AVP. Basal plasma AVP in 203 children and adolescents (105 males and 98 females; ages, 1 day to 18 years) averaged 1.1 ± 0.6 ng/L. There was no significant difference between males and females and no correlation with age. In 16 healthy adult controls, plasma AVP averaged 1.0 ± 0.5 ng/L.
The following articles in journals at HighWire Press have cited this article:
![]() |
M. Masia, J. Papassotiriou, N. G. Morgenthaler, I. Hernandez, C. Shum, and F. Gutierrez Midregional Pro-A-Type Natriuretic Peptide and Carboxy-Terminal Provasopressin May Predict Prognosis in Community-Acquired Pneumonia Clin. Chem., December 1, 2007; 53(12): 2193 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Szinnai, N. G. Morgenthaler, K. Berneis, J. Struck, B. Muller, U. Keller, and M. Christ-Crain Changes in Plasma Copeptin, the C-Terminal Portion of Arginine Vasopressin during Water Deprivation and Excess in Healthy Subjects J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3973 - 3978. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katan, N. G. Morgenthaler, K. C. S. Dixit, J. Rutishauser, G. E. Brabant, B. Muller, and M. Christ-Crain Anterior and Posterior Pituitary Function Testing with Simultaneous Insulin Tolerance Test and a Novel Copeptin Assay J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2640 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jochberger, N. G. Morgenthaler, V. D. Mayr, G. Luckner, V. Wenzel, H. Ulmer, S. Schwarz, W. R. Hasibeder, B. E. Friesenecker, and M. W. Dunser Copeptin and Arginine Vasopressin Concentrations in Critically Ill Patients J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4381 - 4386. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin Clin. Chem., January 1, 2006; 52(1): 112 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kirchlechner, D. Y Koller, R. Seidl, and F. Waldhauser Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride Arch. Dis. Child., June 1, 1999; 80(6): 548 - 552. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |